Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × UNKNOWN × sintilimab × Clear all

Phase

Phase 2 5 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 8 INDUSTRY 3 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

sintilimab 1 nedaplatin 1 S 1 (combination) 1 Paclitaxel 1 Neoadjuvant Therapy 1 Lidocaine 1 Immune Checkpoint Inhibitors 1 Cisplatin 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05484024 2022-08-02

Short-course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer

ChineseAMS

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡